Co-Authors
This is a "connection" page, showing publications co-authored by Ahmet Inkaya and Serhat Ünal.
Connection Strength
2.316
-
Pretreatment serum uric acid level is not a surrogate marker for the outcome of favipiravir treatment in COVID-19 patients. Turk J Med Sci. 2021 Aug 16.
Score: 0.962
-
Outcome of noncritical COVID-19 patients with early hospitalization and early antiviral treatment outside the ICU Turk J Med Sci. 2021 04 30; 51(2):411-420.
Score: 0.236
-
Thirty-day readmission rate of COVID-19 patients discharged from a tertiary care university hospital in Turkey: an observational, single-center study. Int J Qual Health Care. 2021 Feb 20; 33(1).
Score: 0.233
-
The effects of blood group types on the risk of COVID-19 infection and its clinical outcome Turk J Med Sci. 2020 06 23; 50(4):679-683.
Score: 0.222
-
Polypharmacy and drug-related problems among people living with HIV/AIDS: a single-center experience Turk J Med Sci. 2019 Feb 11; 49(1):222-229.
Score: 0.202
-
Determination of medication adherence and related factors among people living with HIV/AIDS in a Turkish university hospital Turk J Med Sci. 2019 Feb 11; 49(1):198-205.
Score: 0.202
-
[Comparison of immunochromatographic (IC) and real-time polymerase chain reaction (Rt-PCR) tests for screening Neisseria gonorrhoeae, Chlamydia trachomatis, Ureaplasma spp. and Mycoplasma spp. in HIV-infected men]. Mikrobiyol Bul. 2019 Jan; 53(1):37-42.
Score: 0.201
-
COVID-19 Vaccination Scenarios: A Cost-Effectiveness Analysis for Turkey. Vaccines (Basel). 2021 Apr 18; 9(4).
Score: 0.059